- 全部删除
您的购物车当前为空
CRM1-IN-1 (Compound KL1) 为非共价CRM1抑制剂,能诱导核CRM1降解(IC50: 0.27 μM),抑制CRM1介导的核输出与细胞增殖,同时触发结直肠癌细胞凋亡 (apoptosis)。
CRM1-IN-1 (Compound KL1) 为非共价CRM1抑制剂,能诱导核CRM1降解(IC50: 0.27 μM),抑制CRM1介导的核输出与细胞增殖,同时触发结直肠癌细胞凋亡 (apoptosis)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
CRM1-IN-1 相关产品
| 产品描述 | CRM1-IN-1 (Compound KL1), a noncovalent inhibitor of CRM1, promotes nuclear degradation of CRM1 with an IC50 of 0.27 μM, inhibits CRM1-mediated nuclear export, suppresses cell proliferation, and induces apoptosis in colorectal cancer cells [1]. |
| 分子量 | 504.7 |
| 分子式 | C29H48N2O5 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容